Literature DB >> 10982321

RNase L-independent specific 28S rRNA cleavage in murine coronavirus-infected cells.

S Banerjee1, S An, A Zhou, R H Silverman, S Makino.   

Abstract

We characterized a novel 28S rRNA cleavage in cells infected with the murine coronavirus mouse hepatitis virus (MHV). The 28S rRNA cleavage occurred as early as 4 h postinfection (p.i.) in MHV-infected DBT cells, with the appearance of subsequent cleavage products and a decrease in the amount of intact 28S rRNA with increasing times of infection; almost all of the intact 28S rRNA disappeared by 24 h p.i. In contrast, no specific 18S rRNA cleavage was detected in infected cells. MHV-induced 28S rRNA cleavage was detected in all MHV-susceptible cell lines and all MHV strains tested. MHV replication was required for the 28S rRNA cleavage, and mature cytoplasmic 28S rRNA underwent cleavage. In certain combination of cells and viruses, pretreatment of virus-infected cells with interferon activates a cellular endoribonuclease, RNase L, that causes rRNA degradation. No interferon was detected in the inoculum used for MHV infection. Addition of anti-interferon antibody to MHV-infected cells did not inhibit 28S rRNA cleavage. Furthermore, 28S rRNA cleavage occurred in an MHV-infected mouse embryonic fibroblast cell line derived from RNase L knockout mice. Thus, MHV-induced 28S rRNA cleavage was independent of the activation of RNase L. MHV-induced 28S rRNA cleavage was also different from apoptosis-related rRNA degradation, which usually occurs concomitantly with DNA fragmentation. In MHV-infected 17Cl-1 cells, 28S rRNA cleavage preceded DNA fragmentation by at least 18 h. Blockage of apoptosis in MHV-infected 17Cl-1 cells by treatment with a caspase inhibitor did not block 28S rRNA cleavage. Furthermore, MHV-induced 28S rRNA cleavage occurred in MHV-infected DBT cells that do not show apoptotic signs, including activation of caspase-3 and DNA fragmentation. Thus, MHV-induced 28S rRNA cleavage appeared to differ from any rRNA degradation mechanism described previously.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982321      PMCID: PMC102073          DOI: 10.1128/jvi.74.19.8793-8802.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

Review 1.  The interferon system. A bird's eye view of its biochemistry.

Authors:  G C Sen; P Lengyel
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

2.  RNA of mouse hepatitis virus.

Authors:  M M Lai; S A Stohlman
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

Review 3.  The biology and pathogenesis of coronaviruses.

Authors:  H Wege; S Siddell; V ter Meulen
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

4.  Intracellular protein synthesis and the in vitro translation of coronavirus JHM mRNA.

Authors:  S Siddell; H Wege; A Barthel; V ter Meulen
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

5.  Coronavirus JHM: intracellular protein synthesis.

Authors:  S Siddell; H Wege; A Barthel; V ter Meulen
Journal:  J Gen Virol       Date:  1981-03       Impact factor: 3.891

6.  Evolution of mouse hepatitis virus: detection and characterization of spike deletion variants during persistent infection.

Authors:  C L Rowe; S C Baker; M J Nathan; J O Fleming
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex.

Authors:  D Etchison; S C Milburn; I Edery; N Sonenberg; J W Hershey
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

8.  A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion.

Authors:  S Makino; M Joo; J K Makino
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2.

Authors:  J G Keck; L H Soe; S Makino; S A Stohlman; M M Lai
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

10.  Defective-interfering particles of murine coronavirus: mechanism of synthesis of defective viral RNAs.

Authors:  S Makino; C K Shieh; J G Keck; M M Lai
Journal:  Virology       Date:  1988-03       Impact factor: 3.616

View more
  29 in total

Review 1.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

Review 2.  Tinkering with translation: protein synthesis in virus-infected cells.

Authors:  Derek Walsh; Michael B Mathews; Ian Mohr
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

3.  RNase L plays a role in the antiviral response to West Nile virus.

Authors:  Svetlana V Scherbik; Jayashree M Paranjape; Bronislava M Stockman; Robert H Silverman; Margo A Brinton
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist.

Authors:  Ye Ye; Kevin Hauns; Jeffrey O Langland; Bertram L Jacobs; Brenda G Hogue
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

5.  Aberrant expression of miR-638 contributes to benzo(a)pyrene-induced human cell transformation.

Authors:  Daochuan Li; Qing Wang; Caixia Liu; Huawei Duan; Xiaowen Zeng; Bo Zhang; Xiaodong Li; Jian Zhao; Shifu Tang; Zhifang Li; Xiumei Xing; Ping Yang; Liping Chen; Junling Zeng; Xiaonian Zhu; Shixin Zhang; Zhengbao Zhang; Lu Ma; Zhini He; Erman Wang; Yongmei Xiao; Yuxin Zheng; Wen Chen
Journal:  Toxicol Sci       Date:  2011-11-01       Impact factor: 4.849

6.  Inhibition of protein kinase R activation and upregulation of GADD34 expression play a synergistic role in facilitating coronavirus replication by maintaining de novo protein synthesis in virus-infected cells.

Authors:  Xiaoxing Wang; Ying Liao; Pei Ling Yap; Kim J Png; James P Tam; Ding Xiang Liu
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

7.  Varicella-zoster virus does not significantly induce cell defence mechanism mediated by the 2-5A/RNase L pathway during its replication cycle.

Authors:  Nathalie Desloges; Markus Rahaus; Manfred H Wolff
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

8.  Murine coronavirus replication induces cell cycle arrest in G0/G1 phase.

Authors:  Chun-Jen Chen; Shinji Makino
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Novel small-molecule inhibitors of transmissible gastroenteritis virus.

Authors:  Cheng-Wei Yang; Yung-Ning Yang; Po-Huang Liang; Chi-Min Chen; Wei-Liang Chen; Hwan-You Chang; Yu-Sheng Chao; Shiow-Ju Lee
Journal:  Antimicrob Agents Chemother       Date:  2007-08-20       Impact factor: 5.191

10.  A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein.

Authors:  Wataru Kamitani; Cheng Huang; Krishna Narayanan; Kumari G Lokugamage; Shinji Makino
Journal:  Nat Struct Mol Biol       Date:  2009-10-18       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.